Sanofi Posts More Positive Olipudase Alfa Data As Approval Decisions Loom

First Potential Therapy For Rare Lysosomal Storage Disease

Paperwork
Sanofi amasses more data on olipudase alfa • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Rare Diseases

More from Scrip